Ignite Creation Date:
2025-12-25 @ 5:08 AM
Ignite Modification Date:
2026-07-17 @ 1:35 AM
Study NCT ID:
NCT05945927
Status:
COMPLETED
Last Update Posted:
2025-10-10
First Post:
2023-06-29
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study to Evaluate the Safety and Effectiveness of Trastuzumab Emtansine (T-DM1) as Therapy in Chinese Participants With HER2 Positive Advanced Breast Cancer
Sponsor:
Hoffmann-La Roche
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Breast Cancer | View |
Keywords: